Chlorella
Green-microalgae biomass marketed as a nutritional supplement. Trials and meta-analyses use heterogeneous species, processing, doses, and populations, with findings that do not define a unitary active compound or exposure model.
Pharmacokinetic model
A route-level PK model for chlorella is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Supplement
- Suggested cadence
- once daily
Research behind this entry
-
Effect of Chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials
Meta-analysis pooled 19 randomized trials with 797 participants and reported modest changes in selected lipids, blood pressure, and glucose, while other outcomes were unchanged. Heterogeneous products and populations…
-
Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study
Sixty-three mildly hypercholesterolemic adults were randomized to 5 g/day Chlorella or placebo for four weeks. Selected lipid and carotenoid endpoints differed, but the short product-specific trial does not establish…
-
Chlorella-derived multicomponent supplementation increases aerobic endurance capacity in young individuals.
This citation reports an animal study involving Chlorella. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
3 published studies referenced in the app, each with a plain-language summary.